Cargando…
A combined computational and functional approach identifies IGF2BP2 as a driver of chemoresistance in a wide array of pre-clinical models of colorectal cancer
AIM: Chemoresistance is a major cause of treatment failure in colorectal cancer (CRC) therapy. In this study, the impact of the IGF2BP family of RNA-binding proteins on CRC chemoresistance was investigated using in silico, in vitro, and in vivo approaches. METHODS: Gene expression data from a well-c...
Autores principales: | Kendzia, Sandra, Franke, Susanne, Kröhler, Tarek, Golob-Schwarzl, Nicole, Schweiger, Caroline, Toeglhofer, Anna M., Skofler, Christina, Uranitsch, Stefan, El-Heliebi, Amin, Fuchs, Julia, Punschart, Andreas, Stiegler, Philipp, Keil, Marlen, Hoffmann, Jens, Henderson, David, Lehrach, Hans, Yaspo, Marie-Laure, Reinhard, Christoph, Schäfer, Reinhold, Keilholz, Ulrich, Regenbrecht, Christian, Schicho, Rudolf, Fickert, Peter, Lax, Sigurd F., Erdmann, Frank, Schulz, Marcel H., Kiemer, Alexandra K., Haybaeck, Johannes, Kessler, Sonja M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10227963/ https://www.ncbi.nlm.nih.gov/pubmed/37248468 http://dx.doi.org/10.1186/s12943-023-01787-x |
Ejemplares similares
-
Separation of low and high grade colon and rectum carcinoma by eukaryotic translation initiation factors 1, 5 and 6
por: Golob-Schwarzl, Nicole, et al.
Publicado: (2017) -
Correction: Separation of low and high grade colon and rectum carcinoma by eukaryotic translation initiation factors 1, 5 and 6
por: Golob-Schwarzl, Nicole, et al.
Publicado: (2023) -
Modeling of Personalized Treatments in Colon Cancer Based on Preclinical Genomic and Drug Sensitivity Data
por: Keil, Marlen, et al.
Publicado: (2021) -
IMP2/IGF2BP2 expression, but not IMP1 and IMP3, predicts poor outcome in patients and high tumor growth rate in xenograft models of gallbladder cancer
por: Kessler, Sonja M., et al.
Publicado: (2017) -
Molecular dissection of colorectal cancer in pre-clinical models identifies biomarkers predicting sensitivity to EGFR inhibitors
por: Schütte, Moritz, et al.
Publicado: (2017)